Cite
HARVARD Citation
Joshi, M. et al. (2020). Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation. Leukemia & lymphoma. 61 (1), pp. 91-97. [Online].